In this task, you're given a paragraph from the research paper and your task is to generate a suitable title for the research paper based on the given paper. Under 100 words is a good title length.
Example: The severe acute respiratory syndrome (SARS) epidemic originating from China in 2002 was caused by a previously uncharacterized coronavirus that could be identified by specific RT-PCR amplification. Efforts to control future SARS outbreaks depend on the accurate and early identification of SARS-CoV infected patients. A real-time fluorogenic RT-PCR assay based on the 3 -noncoding region (3 -NCR) of SARS-CoV genome was developed as a quantitative SARS diagnostic tool. The ideal amplification efficiency of a sensitive SARS-CoV RT-PCR assay should yield an E value (PCR product concentration increase per amplification cycle) equal to 2.0. It was demonstrated that the 3 -NCR SARS-CoV based RT-PCR reactions could be formulated to reach excellent E values of 1.81, or 91% amplification efficacy. The SARS-CoV cDNA preparations derived from viral RNA extract and the cloned recombinant plasmid both exhibit the identical amplification characteristics, i.e. amplification efficacy using the same PCR formulation developed in this study. The viral genomic copy (or genomic equivalences, GE) per infectious unit (GE/pfu) of SARS-CoV used in this study was also established to be approximate 1200-1600:1. The assay's detection sensitivity could reach 0.005 pfu or 6-8 GE per assay. It was preliminarily demonstrated that the assay could efficiently detect SARS-CoV from clinical specimens of SARS probable and suspected patients identified in Taiwan. The 3 -NCR based SARS-CoV assay demonstrated 100% diagnostic specificity testing samples of patients with acute respiratory disease from a non-SARS epidemic region.
Example solution: Development and evaluation of an efficient 3 -noncoding region-based SARS coronavirus (SARS-CoV) RT-PCR assay for detection of SARS-CoV
Example explanation: It's a correct title because the paragraph described the development of 3 -noncoding region of SARS-CoV genome and assay efficiently detecting SARS-CoV from clinical specimens.

Problem: Cloning and Site-Directed Mutagenesis. The expression vector pET11d/FMDV (1) was used as a template for all site-directed Lb pro mutants (amino acids . Human ISG15 (Cys78Ser) and Met1 diubiquitin constructs were cloned into the pOPIN-B His-tagged expression vector (2). A codon-optimized ISG15 was obtained from GeneArt Gene Synthesis (Invitrogen) and cloned in frame to the intein/chitin binding domain pTXB1 vector (New England BioLabs) using conventional cloning methods. Site-directed mutagenesis was performed according to the QuikChange method. Plasmids for cell transfection assays (FLAG-ISG15, UBE1L, UBE2L6, and HERC5 of human origin) were cloned into the pcDNA3.1 mammalian expression vector. Protein Expression and Purification. Lb pro was expressed and purified according to ref. 3. His-tagged ISG15 and Met1 diubiquitin were expressed in Escherichia coli Rosetta2 (DE3) pLacI (Novagen). Cultures were grown to OD 600 (0.6-0.8) and induced with 0.2 mM Isopropyl -D-1-thiogalactopyranoside for 16 h at 18C. Cell pellets were resuspended in 30 mL of lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 2 mM -mercaptoethanol) and frozen at 80C. Thawed pellets were supplemented with an EDTA-free Complete Protease Inhibitor tablet (Roche), 1 mg/mL lysozyme, and 0.1 mg/mL DNaseI and incubated on ice for 10 min. The cell suspension was sonicated, and cell debris was cleared by centrifugation at 50,000 g for 30 min. The cleared lysate was incubated with TALON Superflow resin (GE Healthcare) for 10 min and washed with 1 L of lysis buffer by gravity flow. Protein was eluted with lysis buffer supplemented with 250 mM imidazole. Purified proteins were dialyzed for 16 h into lysis buffer to remove excess imidazole. ISG15-intein protein was expressed identically to His-tagged proteins but purified with chitin resin (New England BioLabs) as described previously (4, 5). AMC Fluorescence Measurements. ISG15-AMC cleavage assays were performed as described previously (6) with minor modifications. In each reaction, 10 L of 2 M ISG15-AMC (2 concentration) was mixed with 10 L enzyme (2 concentration) in AMC assay buffer (50 mM Tris, pH 8.0, 10 mM DTT). The reactions were monitored using ex = 350 nm and em = 450 nm. Fluorescence Polarization Assays. All ubiquitin/ubiquitin-like TAMRA assays were performed according to ref. 7. Briefly, enzymes and substrates were diluted in dilution buffer (50 mM Tris, pH 8.0, 10 mM DTT). Substrate concentrations remained constant at 150 nM, while enzyme concentrations varied based on cleavage efficiency. Cleavage assays were performed in a black 384-well plate (Corning), and fluorescence polarization (FP) measurements were made with a 550-nm excitation filter and a 590-nm emission filter using a Pherastar plate reader (BMG Labtech). All measurements were compared with substrate only (negative) and 25 nM KG-TAMRA peptide (positive) reference standards. Kinetics. ISG15-TAMRA was used as a substrate for determination of Lb pro Michaelis-Menten kinetics. The change in FP on Lb pro hydrolysis was measured in a black 384-well plate using a PheraStar plate reader (BMG Labtech): ex = 550 nm and em = 590 nm. Reactions were incubated at 25C in a total volume of 20 L in FP kinetics buffer (25 mM Tris, pH 8.5, 2 mM DTT, 0.1 mg/mL BSA). In each well, 10 L ISG15-TAMRA (2 final concentration) was mixed with 10 L of 40 nM enzyme (2 final concentration). The ISG15-TAMRA concentration was varied Swatek et al. www.pnas.org/cgi/content/short/1710617115
Solution: Supporting Information